SHARE-BASED COMPENSATION - Option activity (Details) |
12 Months Ended | |
|---|---|---|
|
Dec. 31, 2025
$ / shares
shares
|
Dec. 31, 2024
$ / shares
shares
|
|
| Options outstanding | ||
| Outstanding, vested and expected to vest at the beginning of the period | shares | 194,000 | |
| Granted | shares | 33,775 | |
| Outstanding, vested and expected to vest at the end of the period | shares | 227,775 | 194,000 |
| Exercisable | shares | 209,199 | |
| Weighted Average Exercise Price | ||
| Weighted Average Exercise price, Beginning of the period | $ / shares | $ 101.07 | |
| Weighted Average Exercise price, granted | $ / shares | 15.94 | |
| Weighted Average Exercise price, End of the period | $ / shares | 88.45 | $ 101.07 |
| Exercisable | $ / shares | $ 90.91 | |
| Weighted Average Remaining Contractual Term (in years) | ||
| Weighted average contractual life | 6 years 9 months 3 days | 7 years 4 months 9 days |
| Weighted average remaining contractual term, Granted | 9 years 29 days | |
| Weighted Average Remaining Contractual Term, Exercisable | 6 years 6 months 18 days | |
| X | ||||||||||
- Definition Weighted average remaining contractual term for granted portions of options outstanding. No definition available.
|
| X | ||||||||||
- Definition Represents the details pertaining to Weighted Average Remaining Contractual Term. No definition available.
|
| X | ||||||||||
- Definition The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Gross number of share options (or share units) granted during the period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Number of options outstanding, including both vested and non-vested options. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period. No definition available.
|
| X | ||||||||||
- Definition Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|